Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to DRUG APPROVALS

MDLinx

The Science Behind the Drug That May Stop Alzheimer’s Disease in Its Tracks

Neurology June 21st 2022

OBR Oncology

Once Hopeful Prostate Cancer Drug Fails Phase II Test

Oncology, Medical June 6th 2022

Endocrine Connections

Anaplastic Thyroid Cancer: Genome-based Search for New Targeted Therapy Options

Oncology, Medical May 31st 2022

Healio

FDA Rejects New Drug Application for Surufatinib to Treat Advanced Neuroendocrine Tumors

Oncology, Medical May 31st 2022

Monthly Prescribing Reference (MPR)

FDA Approves First-in-Class Treatment for Type 2 Diabetes

Endocrinology, Diabetes, Metabolism May 24th 2022

MDLinx

Experimental drug breaks record for weight loss in latest clinical trial results

Endocrinology, Diabetes, Metabolism May 17th 2022